Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Research news

Putting the sea into cancer therapy

Tudor Toma

Genome Biology 2001, 2:spotlight-20010806-01  doi:10.1186/gb-spotlight-20010806-01

The electronic version of this article is the complete one and can be found online at:


Published:6 August 2001

© 2001 BioMed Central Ltd

Research news

Under normal circumstances DNA mutations occurring in a cell are fixed by the cell's own DNA-repair mechanisms. These include nucleotide-excision repair (NER), which removes damaged sections of DNA and replaces them with the correct sequence. In the August Nature Medicine, Yuji Takebayashi and colleagues from the US National Cancer Institute, Bethesda, Maryland demonstrate a new cell-killing mechanism mediated by NER that can be exploited to improve cancer therapy (Nature Med 2001, 7:961-966).

Takebayashi et al. studied the effects of the novel anticancer drug ecteinascidin 743 (Et743), a natural product isolated from the Caribbean sea squirt (Ecteinascidia turbinate), on cells with the chromosome alterations seen in Xeroderma pigmentosum - a hereditary condition in which the affected individual is chronically hypersensitive to UV light. They found that Et743 alters the NER process, and rather than repairing the damaged DNA it causes the NER machinery to create lethal breaks in the DNA, thus killing cells.

This is a unique and previously unrecognised mechanism of killing cancer cells and the authors suggest that Et743 could be of considerable use in the treatment of cisplatin-resistant ovarian carcinoma, a cancer which exhibits enhanced NER activity.

References

  1. [http://medicine.nature.com] webcite

    Takebayashi Y, Pourquier P, Zimonjic DB, Nakayama K, Emmert S, Ueda T, Urasaki Y, Kanzaki A, Akiyama Si, Popescu N et al.: Anitproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair.Nature Med 2001, 7:961-966

  2. [http://www.nci.nih.gov] webcite

    National Cancer Institute

  3. [http://www.xps.org/ ] webcite

    The Xeroderma Pigmentosum Society